3T3-L1 세포에서 Adipogenesis 조절을 통한 Demethoxycurcumin 의 항비만 활성
Anti-obese Function of Demethoxycurcumin through Suppression of Adipogenesis in 3T3-L1 Cells
2
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
Obesity is a major health problem and it also closely associated with metabolic disorders. Adipogenesis was defined as a differentiation process of preadipocytes into adipocytes. Thus, adipogenesis is a potential target to treat or prevent obesity. Demethoxycurcumin (DCCM) has been reported to possess potent antioxidant and proapoptotic properties. However, its role in obesity prevention remains unknown. Here, we demonstrate the potential role of DCCM in 3T3-L1 cells. We found that 1-50 μM of DCCM showed no effect on the viability of 3T3-L1 preadipocytes. We also found DCCM dose-dependently inhibited adipogenesis, accompanied by reduced level of adipogenic transcriptional factors such as C/EBPβ and PPARγ. Our results implicate that the inhibitory action of DCCM is strongly linked to the reduction of C/EBPβ and PPARγ. These evidences provide useful information for the development of obesity-related nutri-cosmetics design.
Abstract
Obesity is a major health problem and it also closely associated with metabolic disorders. Adipogenesis was defined as a differentiation process of preadipocytes into adipocytes. Thus, adipogenesis is a potential target to treat or prevent obesity. Demethoxycurcumin (DCCM) has been reported to possess potent antioxidant and proapoptotic properties. However, its role in obesity prevention remains unknown. Here, we demonstrate the potential role of DCCM in 3T3-L1 cells. We found that 1-50 μM of DCCM showed no effect on the viability of 3T3-L1 preadipocytes. We also found DCCM dose-dependently inhibited adipogenesis, accompanied by reduced level of adipogenic transcriptional factors such as C/EBPβ and PPARγ. Our results implicate that the inhibitory action of DCCM is strongly linked to the reduction of C/EBPβ and PPARγ. These evidences provide useful information for the development of obesity-related nutri-cosmetics design.
참고문헌 (14)
- 김기홍, "식품생리활성물질을 이용한 지방세포 분화조절 연구현황 및 전망", 식품과학과산업, 42, pp.51~57 (2009)
- 김유정, "난황추출물 식이보조제와 고주파관리의 비만 개선 효과", 대한피부미용학회지, 8(2), pp.263~264 (2010), 대한피부미용학회
- 노재경, "미세염증제어를 통한 비만예방 식사요법", 대한피부미용학회지, 10(1), pp.1~6 (2012), 대한피부미용학회
- 성영환, "캡사이신이 함유된 조성물을 이용한 복부마사지가 성인 비만여성의 신체조성과 피부온도에 미치는 영향", 대한피부미용학회지, 9(3), pp.1~12 (2011), 대한피부미용학회
- Bhatia V, "Insulin resistance and PPAR insulin sensitizers", Curr. Opin. Investig. Drugs, 7, pp.891~897 (2006)
- Bray GA, "Pathophysiology of obesity", Am. J. Clin. Nutr, 55, pp.488~494 (1992)
- Chearwae W, "Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from tumeric powder", Biochem. Pharmacol, 68, pp.2043~2052 (2004)
- Choy L, "Roles of autocrine TGF-beta receptor and Smad signaling in adipocyte differentiation", J. Cell Biol, 149, pp.667~682 (2000)
- Kim CY, "Curcumin inhibits adipocyte differentiation through modulation of mitotic clonal expansion", J. Nut. Biochem, 22, pp.910~920 (2011)
- Lee YK, "Curcumin exerts antidifferentiation effect through AMPKα-PPAR-γ in 3T3-L1 adipocytes and antiproliferatory effect through AMPKα-COX-2 in cancer cells", J. Agric. Food Chem, 57, pp.305~310 (2009)
- Moller DE, "Role of PPARs in the regulation of obesity-related insulin senstivity and inflammation", Int. J. Obesity, 27, pp.S17~S21 (2003)
- Patwardhan RS, "Dimethoxycurcumin, a metabolically stable analogue of curcumin, exhibits anti-inflammatory activities in murine and human lymphocytes", Biochem. Pharmacol, 82, pp.642~657 (2011)
- Siddiqui MA, "Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin", Food Chem. Toxicol, 50, pp.641~647 (2012)
- Torti FM, "Modulation of adipocyte differentiation by tumor necrosis factor and transforming growth factor beta", J. Cell Biol, 108, pp.1105~1113 (1989)